Latest Articles

Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women.

Relugolix is an oral gonadotropin-releasing hormone receptor antagonist that suppresses sex steroid hormones and is approved as monotherapy for prostate cancer and as a fixed-dose combination with estradiol/norethindrone for the …

Your hormones could be fuelling cancer. Here's what every woman and man needs to know - Hindustan Times

Your hormones could be fuelling cancer. Here's what every woman and man needs to know Hindustan Times

Denying kids access to hormones ‘goes against evidence’ - InDaily Queensland

Denying kids access to hormones ‘goes against evidence’ InDaily Queensland

Denying kids access to hormones 'goes against evidence' - MSN

Denying kids access to hormones 'goes against evidence' MSN

Denying kids access to hormones ‘goes against evidence’ - The Queenslander

Denying kids access to hormones ‘goes against evidence’ The Queenslander

Denying kids access to hormones 'goes against evidence' - Inkl

Denying kids access to hormones 'goes against evidence' Inkl

'I received horrifying cancer diagnosis after doctors told me it was stress and hormones' - The Mirror

'I received horrifying cancer diagnosis after doctors told me it was stress and hormones' The Mirror

What’s The Relationship Between Nutrition And Hormones? - MSN

What’s The Relationship Between Nutrition And Hormones? MSN

Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review).

Endometriosis (EM) is a chronic inflammatory disease that is one of the most common causes of gynecological systemic lesions in women before menopause. The most representative histological feature of EM …

Editorial: Participant characteristics and biological markers for endometriosis diagnosis or prediction of treatment response.